Please Wait.....
Report
Germany Point-of-Care Glucose Testing Market By Product Type (Lancing Devices and Strips, Blood-Glucose Meter), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others): Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2023-06-01 I 84 Pages I Allied Market Research
Glucose testing is an essential procedure as inappropriate glucose levels are indicator of serious medical issues. Glucose testing aids in diagnosis, prevention, and treatment of overweight or diabetes, low blood sugar, and high blood pressure. Point-of-care (PoC) glucose testing is an effective and rapid substitute to typical lab testing, with results available in less than ten minutes. The Germany point-of-care glucose testing market is projected to witness substantial traction during the forecast period in terms of revenue. Factors such as increase in awareness about pre-diabetes, unhealthy lifestyle, and surge in the elderly population are projected to surge the sales of glucose testing devices in Germany.
Rise in diabetes incidence in Germany is a major driver of the point-of-care glucose testing market. Blood glucose level testing is one of the most essential tests performed for quick detection and management of diabetes, which is increasing demand for point-of-care glucose testing devices in the country. In addition, surge in usage of wearable glucose testing gadgets for self-monitoring blood sugar levels is anticipated to offer growth opportunities in the market.However, limited reimbursement schemes and high cost of glucose testing devices are the major factors restraining the growth of the Germany point-of-care glucose testing market. In addition, short lifespan of glucose testing equipment and shortage of experienced technicians to operate the devices hamper the market growth. Furthermore, dearth of suitable infrastructure and lack of technological understanding in rural regions are expected to impede the growth of the Germany point-of-care glucose testing market.
The presence of several established players in the Germany point-of-care glucose testing market creates opportunities for market participants to launch innovative and technologically advanced products. Companies are investing in R&D to provide advanced products in terms of accuracy and efficiency, which is expected to increase their sales. Furthermore, boost in usage of smart glucose meters in clinics and hospitals is projected to open new market prospects.The trend of introducing new product offerings is anticipated to increase in the Germany point-of-care glucose testing market in the near future. In addition, manufacturers are expected to focus on launching products, which are cost-effective and offer advanced features to meet current customer needs. Product launches, investments, and collaborations are some of the other market strategies, which companies are projected to adopt in the market.
The Germany point-of-care glucose testing market is segmented on the basis of product type, application, and end user. By product type the market is divided into lancing devices & strips and blood-glucose meters. According to application, the market is bifurcated into?type 1 diabetes and type 2 diabetes. As per end user, the market is classified into hospitals & clinics, home care settings, and others. Rise in prevalence of diabetes in the nation is increasing the demand for point-of-care glucose testing technology. In accordance with WHO forecast, the number of diabetics in Germany are expected to reach 3.2 million by 2035, presenting considerable opportunities for the Germany point-of-care glucose testing market.
Key market players are focusing on increasing their market presence through new product launches in the country. For instance, in March 2020, Abbott launched Freestyle Libre 2, a real time glucose monitoring system. The device offers various benefits in the form of improved precision and simplicity. In addition, the deployment of real time technology is expected to open new opportunities for industry players in the country.Product developments and partnerships are other market strategies adopted by key players in Germany point-of-care glucose testing market. For instance, in 2018, Roche Diagnostics and Novo Nordisk partnered to support the use of connected insulin pens in people with type 1 diabetes, which enables them to track and manage insulin dosage. The market players focus on leveraging technologies such as Artificial Intelligence (AI) for the development of advanced products. Pricing strategy adopted by companies in the Germany point-of-care glucose testing market is one of the key strategies for attaining profitability. The market players focus on offering cost-effective products to customers, targeting both private and public healthcare institutions. With competitive pricing, companies are able to garner a high share of the market.?
Key Benefits For Stakeholders
Enable informed decision-making process and offer market analysis based on current market situation and estimated future trends.
Analyze the key strategies adopted by major market players in Germany point-of-care glucose testing market.
Assess and rank the top factors that are expected to affect the growth of Germany point-of-care glucose testing market.
Top Player positioning provides a clear understanding of the present position of market players.
Detailed analysis of the Germany point-of-care glucose testing market segmentation assists to determine the prevailing market opportunities.
Identify key investment pockets for various offerings in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Product Benchmarking / Product specification and applications
- Upcoming/New Entrant by Regions
- New Product Development/ Product Matrix of Key Players
- Patient/epidemiology data at country, region, global level
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Product Type
- Lancing Devices and Strips
- Blood-Glucose Meter
- Type
- Lifescan OneTouch Ultra and Lifescan OneTouch Verio
- Accu-Chek Aviva Plus and Accuchek
- Freestyle Lite and Freestyle Precission Neo
- Contour Next
- Others
By Application
- Type-1 Diabetes
- Type-2 Diabetes
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
- Key Market Players
- Roche
- Abbott
- Medtronic
- Siemens Healthineers
- Bayer
- Novo Nordisk
- Pentax Medical
- OptiMedis
- ZEISS Group
- B. Braun Melsungen AG
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter's Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
CHAPTER 5: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
CHAPTER 6: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
8.1. Roche
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Abbott
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Medtronic
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Siemens Healthineers
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Bayer
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Novo Nordisk
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Pentax Medical
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. OptiMedis
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. ZEISS Group
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. B. Braun Melsungen AG
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments
LIST OF TABLES
TABLE 01. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ROCHE: KEY EXECUTIVES
TABLE 05. ROCHE: COMPANY SNAPSHOT
TABLE 06. ROCHE: OPERATING SEGMENTS
TABLE 07. ROCHE: PRODUCT PORTFOLIO
TABLE 08. ROCHE: KEY STRATERGIES
TABLE 09. ABBOTT: KEY EXECUTIVES
TABLE 10. ABBOTT: COMPANY SNAPSHOT
TABLE 11. ABBOTT: OPERATING SEGMENTS
TABLE 12. ABBOTT: PRODUCT PORTFOLIO
TABLE 13. ABBOTT: KEY STRATERGIES
TABLE 14. MEDTRONIC: KEY EXECUTIVES
TABLE 15. MEDTRONIC: COMPANY SNAPSHOT
TABLE 16. MEDTRONIC: OPERATING SEGMENTS
TABLE 17. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 18. MEDTRONIC: KEY STRATERGIES
TABLE 19. SIEMENS HEALTHINEERS: KEY EXECUTIVES
TABLE 20. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 21. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 22. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 23. SIEMENS HEALTHINEERS: KEY STRATERGIES
TABLE 24. BAYER: KEY EXECUTIVES
TABLE 25. BAYER: COMPANY SNAPSHOT
TABLE 26. BAYER: OPERATING SEGMENTS
TABLE 27. BAYER: PRODUCT PORTFOLIO
TABLE 28. BAYER: KEY STRATERGIES
TABLE 29. NOVO NORDISK: KEY EXECUTIVES
TABLE 30. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 31. NOVO NORDISK: OPERATING SEGMENTS
TABLE 32. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 33. NOVO NORDISK: KEY STRATERGIES
TABLE 34. PENTAX MEDICAL: KEY EXECUTIVES
TABLE 35. PENTAX MEDICAL: COMPANY SNAPSHOT
TABLE 36. PENTAX MEDICAL: OPERATING SEGMENTS
TABLE 37. PENTAX MEDICAL: PRODUCT PORTFOLIO
TABLE 38. PENTAX MEDICAL: KEY STRATERGIES
TABLE 39. OPTIMEDIS: KEY EXECUTIVES
TABLE 40. OPTIMEDIS: COMPANY SNAPSHOT
TABLE 41. OPTIMEDIS: OPERATING SEGMENTS
TABLE 42. OPTIMEDIS: PRODUCT PORTFOLIO
TABLE 43. OPTIMEDIS: KEY STRATERGIES
TABLE 44. ZEISS GROUP: KEY EXECUTIVES
TABLE 45. ZEISS GROUP: COMPANY SNAPSHOT
TABLE 46. ZEISS GROUP: OPERATING SEGMENTS
TABLE 47. ZEISS GROUP: PRODUCT PORTFOLIO
TABLE 48. ZEISS GROUP: KEY STRATERGIES
TABLE 49. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 50. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 51. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 52. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 53. B. BRAUN MELSUNGEN AG: KEY STRATERGIES
LIST OF FIGURES
FIGURE 01. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ROCHE: NET SALES, 2020-2022*($MILLION)
FIGURE 21. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ABBOTT: NET SALES, 2020-2022*($MILLION)
FIGURE 24. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. MEDTRONIC: NET SALES, 2020-2022*($MILLION)
FIGURE 27. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. SIEMENS HEALTHINEERS: NET SALES, 2020-2022*($MILLION)
FIGURE 30. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. SIEMENS HEALTHINEERS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. BAYER: NET SALES, 2020-2022*($MILLION)
FIGURE 33. BAYER: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. BAYER: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. NOVO NORDISK: NET SALES, 2020-2022*($MILLION)
FIGURE 36. NOVO NORDISK: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. NOVO NORDISK: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. PENTAX MEDICAL: NET SALES, 2020-2022*($MILLION)
FIGURE 39. PENTAX MEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. PENTAX MEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. OPTIMEDIS: NET SALES, 2020-2022*($MILLION)
FIGURE 42. OPTIMEDIS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. OPTIMEDIS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. ZEISS GROUP: NET SALES, 2020-2022*($MILLION)
FIGURE 45. ZEISS GROUP: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. ZEISS GROUP: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022*($MILLION)
FIGURE 48. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security